# Psyence BioMed Partners with Benuvia for U.S. Ibogaine Manufacturing

> Psyence BioMed and Benuvia launch U.S. pharmaceutical-grade ibogaine production under DEA-registered facility.
- Title: Psyence BioMed Partners with Benuvia for U.S. Ibogaine…
- Summary: Psyence BioMed and Benuvia launch U.S. pharmaceutical-grade ibogaine production under DEA-registered facility. Psyence BioMed's Texas subsidiary partners…
- Keywords: psyence biomed, benuvia operations, tirc, ibogaine, deactivated, u.s. manufacturing, cgm, pharmaceutical-grade, money, business, Psyence, BioMed
- Source: Financialpost — https://financialpost.com/globe-newswire/psyence-biomed-partners-with-dea-registered-benuvia-operations-to-establish-u-s-manufacture-of-pharmaceutical-grade-ibogaine
- Read time: 1 min
- Topics: psyence biomed, benuvia operations, tirc, ibogaine, deactivated, u.s. manufacturing, cgm, pharmaceutical-grade, money, business
## Partnership Announced
Psyence BioMed's Texas subsidiary TIRC entered manufacturing partnership with Benuvia Operations for u.s. pharmaceutical-grade ibogaine production.
## Benuvia's Facility
Benuvia operates an 83,000-square-foot dea-registered facility in round rock texas with controlled-substance manufacturing capabilities.
## Manufacturing Plan
Partnership connects tirc's exclusive u.s. ibogaine supply with benuvia's u.s. manufacturing infrastructure for pharmaceutical-grade production.
## Regulatory Pathway
Benuvia holds approximately half of u.s. ibogaine production quota and is advancing dea import permits for planned u.s. manufacturing.
## CEO Statement
Jody Aufrichtig said benuvia brings dea-registered u.s. facility with quota and systems to create end-to-end ibogaine production pathway.
## Key takeaway

Psyence BioMed's Texas subsidiary partners with Benuvia to manufacture ibogaine in the U.S. using DEA-registered facilities.